EMERGE
Report
- Report Number
- 2124215-2025-11060
- Event Type
- Death
- Date Received
- February 24, 2025
- Date of Event
- January 24, 2025
- Report Date
- February 24, 2025
- Manufacturer
- BOSTON SCIENTIFIC CORPORATION
- Product Code
- LOX
- UDI-DI
- 08714729806257
- PMA / PMN Number
- K113220,
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MA, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
G4 PMA/510(K): K163174.
IT WAS REPORTED THAT PERORATION AND DEATH OCCURRED. ON (B)(6) 2025, THE PATIENT PRESENTED WITH STABLE ANGINA. THE SAME DAY THE PATIENT UNDERWENT PERCUTANEOUS CORONARY INTERVENTION USING CUTTING BALLOON ANGIOPLASTY IN THE PROXIMAL LEFT ANTERIOR DESCENDING (LAD). THE LESION WAS PREDILATED WITH A 15 MM X 3.00 MM WOLVERINE CORONARY CUTTING BALLOON AT THE LAD. INTRAVASCULAR ULTRASOUND (IVUS) WAS PERFORMED, AND ADDITIONAL DILATATION WAS PERFORMED WITH A 3.50 MM X 15 MM EMERGE BALLOON AND A 4.00 MM X 8 MM EMERGE BALLOON. AN ELLIS CLASS 3 PERFORATION IN THE PROXIMAL LAD OCCURRED WHICH WAS CONSIDERED TO HAVE BEEN CAUSED BY THE 3.50 X 15MM EMERGE BALLOON. THE PERFORATION WAS COVERED INITIALLY WITH A 4.00 X 20 MM NON-BOSTON SCIENTIFIC (NON-BSC) STENT AND PERICARDIOCENTESIS PERFORMED. A 3.00 X 20 MM NON-BSC STENT WAS IMPLANTED DISTAL TO THE INITIAL COVER STENT IN VIEW OF PERSISTENT EXTRAVASATION. CARDIOPULMONARY RESUSCITATION (CPR) WAS STARTED DUE TO PROFOUND HYPOTENSION. THE PATIENT WAS INTUBATED, AND VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION (VA ECMO) WAS INSERTED. THE LEFT MAIN (LM) WAS RE-ENGAGED VIA THE LEFT FEMORAL ARTERY (LFA) USING AN 8FR NON-BSC GUIDING CATHETER. IT WAS SEEN THAT THE PERFORATION WAS SEALED, AND THE FIRST DIAGONAL WAS LOST BUT THERE WAS SATISFACTORY IVUS AND ANGIOGRAPHIC RESULT. TRANSESOPHAGEAL ECHOCARDIOGRAPHY (TEE) SHOWED RESTRICTION AND A CALCIFIED AORTIC VALVE. BALLOON VALVULOPLASTY WAS PERFORMED WITH A 20 MM NON-BSC BALLOON. A REPERFUSION SHEATH 6FR WAS INSERTED TO THE RIGHT SUPERFICIAL FEMORAL ARTERY (SFA). THE PATIENT WAS ON ECMO WITH LOW FLOWS AND CHUGGING. THE PERICARDIAL DRAIN HAD BEEN REMOVED. THERE WAS CONCERN FOR RIGHT-SIDED CREPITUS AND A CHEST X RAY WAS OBTAINED. THE PATIENT HAD WORSENING PRESSOR REQUIREMENTS STATUS POST 7 LITERS OF INTRAVENOUS FLUID PROMPTING TRANSFUSION OF MULTIPLE BLOOD PRODUCTS. THE PATIENT SUFFERED A CARDIAC ARREST AND RETURN OF SPONTANEOUS CIRCULATION (ROSC) WAS ACHIEVED AFTER 1 ROUND OF CPR, EPI AND BICARB. BEDSIDE CARDIAC ULTRASOUND SHOWED MODERATE PERICARDIAL EFFUSION. THE NEXT DAY, THE PATIENT CONDITION WAS FURTHER COMPLICATED BY ECMO CHUGGING AND ELEVATED CENTRAL VENOUS PRESSURE (CVP). ADDITIONALLY, THE PATIENT EXPERIENCED AN ACUTE ISCHEMIC STROKE OF THE LEFT OCCIPITAL AND CEREBELLAR LOBES WITHOUT THROMBOLYSIS OR THROMBECTOMY, AND DEVELOPED THROMBOCYTOPENIA, LEADING TO THE DISCONTINUATION OF HEPARIN. ON (B)(6) 2025, THE PATIENT SUBSEQUENTLY UNDERWENT REPEAT PERICARDIAL DRAINAGE WITH PIGTAIL PLACEMENT AND SWAN GANZ INSERTION IN CATHETERIZATION LAB. ON (B)(6) 2025, THE PATIENT NOTED TO HAVE WORSENING PRESSOR REQUIREMENTS, WORSENING LACTATE, WORSENING RENAL FUNCTION, AND DEVELOPED SUSTAINED VENTRICULAR TACHYCARDIA. THE PATIENT WAS STARTED ON AMIODARONE. THE PATIENT WAS WEANED OFF SEDATION WITH NO NEUROLOGIC RESPONSE NOTED OVER COURSE OF 24 HOURS. ON (B)(6) 2025, THE PATIENT WAS NOTED TO BE ASYSTOLE ON MONITOR. THE ECMO CIRCUIT WAS CLAMPED, AND THE VENTILATOR STOPPED. THE SUBJECT WAS PRONOUNCED AS DECEASED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 612290 | EMERGE | CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS | LOX | BOSTON SCIENTIFIC CORPORATION | H7493918915350 | 0034299988 | 08714729806257 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 75 YR | Male | Death |